BioCentury
ARTICLE | Clinical News

EN3202 extended release oxymorphone: Phase III

August 26, 2002 7:00 AM UTC

Endo Pharmaceuticals Holdings Inc. (ENDP), Chadds Ford, Penn. Penwest Pharmaceuticals Co. (PPCO), Patterson, N.Y. Product: EN3202 extended release oxymorphone Business: Neurological Therapeutic cate...